60.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GEHC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$68.50
Aprire:
$62.15
Volume 24 ore:
17.94M
Relative Volume:
4.85
Capitalizzazione di mercato:
$27.39B
Reddito:
$20.63B
Utile/perdita netta:
$2.15B
Rapporto P/E:
13.18
EPS:
4.5546
Flusso di cassa netto:
$1.51B
1 W Prestazione:
-15.54%
1M Prestazione:
-12.92%
6M Prestazione:
-22.09%
1 anno Prestazione:
-11.46%
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Nome
Ge Healthcare Technologies Inc
Settore
Industria
Telefono
833-735-1139
Indirizzo
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GEHC
Ge Healthcare Technologies Inc
|
60.03 | 31.26B | 20.63B | 2.15B | 1.51B | 4.5546 |
|
ABT
Abbott Laboratories
|
91.87 | 163.10B | 45.13B | 6.28B | 7.40B | 3.5895 |
|
SYK
Stryker Corp
|
312.61 | 123.10B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
79.41 | 105.15B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
56.51 | 86.87B | 20.62B | 3.56B | 3.66B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
81.41 | 47.44B | 6.30B | 1.07B | 1.34B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-15 | Downgrade | UBS | Neutral → Sell |
| 2025-10-13 | Iniziato | Barclays | Equal Weight |
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-05 | Aggiornamento | UBS | Sell → Neutral |
| 2025-03-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-26 | Downgrade | UBS | Neutral → Sell |
| 2024-09-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-09-09 | Iniziato | JP Morgan | Neutral |
| 2024-08-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | HSBC Securities | Buy |
| 2024-02-12 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-30 | Iniziato | Jefferies | Hold |
| 2023-11-27 | Downgrade | UBS | Neutral → Sell |
| 2023-09-19 | Iniziato | Citigroup | Buy |
| 2023-08-25 | Iniziato | Argus | Buy |
| 2023-08-16 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | BofA Securities | Neutral |
| 2023-06-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Iniziato | Oppenheimer | Outperform |
| 2023-04-26 | Iniziato | UBS | Neutral |
| 2023-04-19 | Iniziato | Piper Sandler | Overweight |
| 2023-04-10 | Iniziato | BTIG Research | Neutral |
| 2023-03-13 | Iniziato | Evercore ISI | Outperform |
| 2023-02-17 | Iniziato | Mizuho | Buy |
| 2023-01-19 | Iniziato | Redburn | Buy |
Mostra tutto
Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie
GE HealthCare (GEHC) Stock Falls After Earnings Miss and Guidance Cut - MEXC
GE HealthCare shares tumble after profit miss and guidance cut - Yahoo Finance
Earnings call transcript: GE HealthCare Q1 2026 sees stock drop amid margin pressures - Investing.com
GE Aerospace (GE.US) 1Q Earnings Miss, Cuts FY Guidance; Shares Plunge 14% - AASTOCKS.com
GE HealthCare Stock Drops 11% After Q1 Miss and Cut 2026 Outlook on Tariffs, Costs - International Business Times Australia
GE HealthCare Stock Sinks After Earnings. It’s Lagging Behind the Other Two GEs. - Barron's
GE Healthcare Technologies Inc. Announces Combination of A New Segment That Combines Imaging and Advanced Visualization Solutions - marketscreener.com
GE HealthCare stock hits 52-week low at $62.15 - Investing.com
GE HealthCare (GEHC) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
GE HealthCare (GEHC) Stock Tumbles Nearly 10% on Disappointing Q1 Results - Blockonomi
GE HealthCare Shares Fall After Earnings Miss and Lowered Outlook - Yahoo Finance
GE HealthCare lowers earnings guidance amid rising costs - marketscreener.com
GE HealthCare cuts annual profit forecast as inflation weighs on costs - Yahoo Finance
GE HealthCare Cuts Outlook, Plans to Combine Two Biggest Segments - WSJ
GE HealthCare Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GE HealthCare Drops After Cutting Outlook on War-Related Woes - Bloomberg.com
GE HealthCare Technologies (GEHC) Lags Q1 Earnings Estimates - Yahoo Finance Australia
Why GE HealthCare Shares Are Slipping Today - TipRanks
(GEHC) GE Healthcare Technologies Expects Full Year 2026 Adjusted EPS Range $4.80$5.00, vs. FactSet Est of $5.06 - marketscreener.com
GE HEALTHCARE TECHNOLOGIES ($GEHC) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (GEHC) GE HealthCare Technologies Inc. Reports Q1 Revenue $5.13B, vs. FactSet Est of $5.03B - marketscreener.com
GE HealthCare Technologies : GEHC Slides 1Q'26 Earnings FINAL - marketscreener.com
GE HealthCare shares fall on earnings miss, profit outlook cut By Investing.com - Investing.com Australia
GE HealthCare Technologies : GEHC Release 1Q'26 Earnings FINAL - marketscreener.com
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops - Yahoo Finance
GE HealthCare: Q1 Earnings Snapshot - marketscreener.com
GE HealthCare (NASDAQ: GEHC) grows Q1 sales, closes $2.3B Intelerad deal - Stock Titan
GE HealthCare (Nasdaq: GEHC) posts Q1 2026 results and lowers profit outlook - Stock Titan
GE HealthCare's Q1 revenue tops estimates at $5.1B - Breakingthenews.net
GE HealthCare combines its two biggest businesses into a $14.6B imaging arm - Stock Titan
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market - MarketWatch
GE HealthCare Technologies Q1 2026 earnings preview - MSN
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents - afp.com
GE HealthCare (GEHC) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Lung Cancer Screening Market is experiencing boost at - openPR.com
GE HealthCare Technologies Inc. stock rises Monday, outperforms market - MarketWatch
Miranda Chatziioannou Promoted to Chief Talent Officer at GE HealthCare - hrtoday.in
Utah Medical gains 32% in a year: Should you buy the stock? - msn.com
GEHC unifies bkActiv with Stealth AXiS for live neurosurgery imaging - MSN
Lung Cancer Screening Market is expected to register a CAGR - openPR.com
GE HealthCare management to present at upcoming investor conferences - marketscreener.com
GE HealthCare posts webcast times for two investor conferences - Stock Titan
Wells Fargo Maintains GE HealthCare Technologies (GEHC) Overweight Recommendation - MSN
GE HealthCare (GEHC) Begins Phase 2/3 Trial for Innovative MRI Contrast Agent - Yahoo Finance
GE HealthCare Trial Seeks Manganese MRI Edge With Valuation Upside - Yahoo Finance
GE HealthCare Has Fallen 23% From Its Highs. With Q1 Earnings Days Away, Is Now the Time to Buy? - TIKR.com
General Counsel and Corporate Secretary of GE Healthcare Technologies Inc. & Former 21st General Counsel of the U.S. Department of the Navy - HII
GE HealthCare Technologies Inc. $GEHC Position Trimmed by Coronation Fund Managers Ltd. - MarketBeat
GE HealthCare Technologies (GEHC) Proxy filing Summary - Quartr
symbol__ Stock Quote Price and Forecast - CNN
Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):